SCHEMBL30833286

SCHEMBL30833286

CN1C(=O)CC(=O)c2cc(-n3ccnc3)ncc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 1/20 0.39
CYP1A2 P05177 7/20 0.37
CYP3A4 P08684 7/20 0.37
CYP2D6 P10635 7/20 0.37
CYP2C19 P33261 6/20 0.37
HSD17B10 Q99714 6/20 0.37
ALOX15 P16050 5/20 0.37
CLK4 Q9HAZ1 3/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 3/20 0.37
ALDH1A1 P00352 3/20 0.37
TDP1 Q9NUW8 4/20 0.36
MAPT P10636 3/20 0.36
LOXL2 Q9Y4K0 1/20 0.35
BRD4 O60885 2/20 0.35
PIM1 P11309 1/20 0.35
HRH4 Q9H3N8 1/20 0.34
KDM4E B2RXH2 2/20 0.33
P4HTM Q9NXG6 1/20 0.33
CRBN Q96SW2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833280 0.78 PDE3B (0.44) CYP3A4LMNAMAPTCRBNCYP11B1
SCHEMBL24677008 0.78 PDE3B (0.44) CYP3A4LMNAMAPTCRBNCYP11B1
SCHEMBL29769797 0.74 CD38 (0.35) EGLN2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL30833285 0.73 CYP1A2 (0.35) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL30833279 0.72 OPRK1 (0.35) LMNAGAACYP11B1CYP11B2
SCHEMBL2629369 0.63 CYP3A4 (0.42) EGLN2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL24713314 0.62 LOXL2 (0.44) EGLN2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL9521235 0.61 CYP3A4 (0.58) EGLN2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL25144382 0.61 LOXL2 (0.43) EGLN2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL29495177 0.61 CYP1A2 (0.47) EGLN2CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117580829-A Quinoline and azaquinolines as inhibitors of CD38 勃林格英格翰国际有限公司 2024-02-20 CN disclosed